The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team (Q34063280)
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team |
scientific article |
Statements
1 reference
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team (English)
1 reference
Katzenstein DA
1 reference
Hammer SM
1 reference
Hughes MD
1 reference
Gundacker H
1 reference
Jackson JB
1 reference
Fiscus S
1 reference
Rasheed S
1 reference
Elbeik T
1 reference
Reichman R
1 reference
Japour A
1 reference
Merigan TC
1 reference
Hirsch MS
1 reference
1 October 1996
1 reference
1 reference
335
1 reference
1091-1098
1 reference
Identifiers
1 reference
1 reference